Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Stomatitis 9Lymphoma, Non-Hodgkin 7Lymphoma 7Leukemia 7Hodgkin Disease 7Multiple Myeloma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Leukemia, Myeloid, Acute 5Mucositis 4Leukemia, Lymphocytic, Chronic, B-Cell 4Neoplasms, Plasma Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Head and Neck Neoplasms 3Burkitt Lymphoma 3Blast Crisis 3Recurrence 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Graft vs Host Disease 2Drug-Related Side Effects and Adverse Reactions 2Xerostomia 1Sezary Syndrome 1Sarcoma 1Radiation Injuries 1Primary Myelofibrosis 1

Interventions

Cisplatin 8Radiotherapy 4Pemetrexed 4Cetuximab 4Gemcitabine 3Gefitinib 2Fluorouracil 2Drug Therapy 2Docetaxel 2Carboplatin 2pembrolizumab 1X-Rays 1Vitamin B 12 1Tirapazamine 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Paclitaxel 1Nivolumab 1Nimorazole 1Narrow Band Imaging 1Metformin 1MLN 8237 1LY2940680 1Ipilimumab 1Hydroxyurea 1Gabapentin 1Folic Acid 1Fibroblast Growth Factor 7 1Chemical Fractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Laryngeal Diseases × Fibroblast Growth Factor 7 × Clear all
NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡